Skip to main content
Industry Update
R WE ready for reimbursement? A round up of developments in real-world evidence relating to health technology assessment: part 9
- Alex Simpson and
- Sreeram V Ramagopalan
pp1147–1149
Published Online:23 August 2022
Methodology
Developing a cross-validation tool for evaluating economic evidence in rapid literature reviews
- Xuanqian Xie,
- Chunmei Li,
- Sean Tiggelaar,
- Frances Simbulan,
- Lindsey Falk, and
- James M Brophy
pp1151–1160
Published Online:28 September 2022
Research Article
Evaluating real-world COVID-19 vaccine effectiveness using a test-negative case–control design
- Matthew W Reynolds,
- Alex Secora,
- Alice Joules,
- Lisa Albert,
- Emma Brinkley,
- Tom Kwon,
- Christina Mack,
- Stephen Toovey, and
- Nancy A Dreyer
pp1161–1172
Published Online:23 September 2022
Rivaroxaban for the prevention of outcomes in patients with atrial fibrillation in clinical practice: an indirect comparison of national and international registries
- Francisco Marin,
- Marcelo Sanmartín Fernández,
- Iñaki Lekuona,
- Fernando Arribas,
- Gonzalo Barón-Esquivias,
- Vivencio Barrios,
- Juan Cosin-Sales,
- Román Freixa-Pamias,
- Jaime Masjuan,
- Alejandro I Pérez-Cabeza,
- Vanessa Roldán Schilling,
- José Manuel Vázquez Rodríguez,
- Carles Rafols Priu, and
- Manuel Anguita Sánchez
pp1173–1184
Published Online:23 September 2022
The societal impact of early intensified treatment in patients with type 2 diabetes mellitus
- Foteini Tsotra,
- Mathias Kappel,
- Platon Peristeris,
- Giovanni Bader,
- Eva Levi,
- Nicola Lister,
- Ankur Malhotra, and
- Dennis A Ostwald
pp1185–1199
Published Online:28 September 2022
Meta-Analysis
Effect of home-based exercise programs with e-devices on falls among community-dwelling older adults: a meta-analysis
- Yu-ting Cao,
- Jian-jie Wang,
- Yi-ting Yang,
- Shi-jie Zhu,
- Liang-dong Zheng,
- Wei-wei Lu,
- Rui Zhu, and
- Tao Wu
pp1201–1217
Published Online:23 September 2022